Zobrazeno 1 - 10
of 461
pro vyhledávání: '"David J. Moliterno"'
Autor:
Leo Ungar, Robert M. Clare, Fatima Rodriguez, Bradley J. Kolls, Paul W. Armstrong, Philip Aylward, Claes Held, David J. Moliterno, John Strony, Frans Van de Werf, Lars Wallentin, Harvey D. White, Pierluigi Tricoci, Robert A. Harrington, Kenneth W. Mahaffey, Chiara Melloni
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 24 (2018)
Background Vorapaxar, a protease‐activated receptor‐1 antagonist, is approved for secondary prevention of cardiovascular events but is associated with increased intracranial hemorrhage. Methods and Results TRACER (Thrombin Receptor Antagonist for
Externí odkaz:
https://doaj.org/article/ddd00c1d3d304d07b3f96b5f6ed6633f
Autor:
Sean vanDiepen, Pierluigi Tricoci, Mohua Podder, Cynthia M. Westerhout, Philip E. Aylward, Claes Held, Frans Van de Werf, John Strony, Lars Wallentin, David J. Moliterno, Harvey D. White, Kenneth W. Mahaffey, Robert A. Harrington, Paul W. Armstrong
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 4, Iss 12, Pp n/a-n/a (2015)
Background Perioperative antiplatelet agents potentially increase bleeding after non–ST‐segment elevation (NSTE) acute coronary syndromes (ACS). The protease‐activated receptor 1 antagonist vorapaxar reduced cardiovascular events and was associ
Externí odkaz:
https://doaj.org/article/7928171caf1f4c5f84faa4d547529ed9
Autor:
Valentin Fuster, Biykem Bozkurt, Y. Chandrashekhar, Julia Grapsa, Bonnie Ky, Douglas L. Mann, David J. Moliterno, Kalyanam Shivkumar, Candice K. Silversides, Justine Varieur Turco, Jian’an Wang
Publikováno v:
JACC: CardioOncology. 5:275-277
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab19c7c3ab20ebf32b11279bb22fa291
https://doi.org/10.1016/j.jaccao.2023.03.001
https://doi.org/10.1016/j.jaccao.2023.03.001
Publikováno v:
JACC: Cardiovascular Interventions. 16:875-877
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c280ac57592b63a6bcdaaa32f8199c25
https://doi.org/10.1016/j.jcin.2022.11.031
https://doi.org/10.1016/j.jcin.2022.11.031
Publikováno v:
Current Cardiology Reports. 24:1755-1763
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b009b348f00e7cd8c3eef7f85b13807
https://doi.org/10.1007/s11886-022-01784-4
https://doi.org/10.1007/s11886-022-01784-4
Autor:
Gennaro Sardella, Frans J. Beerkens, George Dangas, Davide Cao, Usman Baber, Samantha Sartori, David J. Cohen, Carlo Briguori, Robert Gil, Johny Nicolas, Zhongjie Zhang, Dariusz Dudek, Vijay Kunadian, Ran Kornowski, Giora Weisz, Bimmer Claessen, Steven Marx, Javier Escaned, Kurt Huber, Timothy Collier, David J. Moliterno, E. Magnus Ohman, Mitchell W. Krucoff, Adnan Kastrati, Phillipe Gabriel Steg, Dominick J. Angiolillo, Shamir Mehta, Richard Shlofmitz, Samin Sharma, Stuart Pocock, Charles Michael Gibson, Roxana Mehran
Publikováno v:
EuroIntervention, 18(11), e897-e909. EuroPCR
BACKGROUND: Prior coronary artery bypass graft surgery (CABG) patients undergoing percutaneous coronary intervention (PCI) are often older and present with multiple comorbidities. Ticagrelor monotherapy after a short course of dual antiplatelet thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05eedba9eb7fb6c4c828831050eaef30
https://pure.amc.nl/en/publications/ticagrelor-with-and-without-aspirin-in-patients-with-a-prior-coronary-artery-bypass-graft-undergoing-percutaneous-coronary-intervention(ed97a00f-b9bc-4925-a901-a68b1611fabf).html
https://pure.amc.nl/en/publications/ticagrelor-with-and-without-aspirin-in-patients-with-a-prior-coronary-artery-bypass-graft-undergoing-percutaneous-coronary-intervention(ed97a00f-b9bc-4925-a901-a68b1611fabf).html
Autor:
Amrita Iyengar, David J. Moliterno
Publikováno v:
Catheterization and Cardiovascular Interventions. 101:274-275
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a0d95828af4a50e6f3754a2497a48de
https://doi.org/10.1002/ccd.30584
https://doi.org/10.1002/ccd.30584
Autor:
Usman Baber, Alessandro Spirito, Samantha Sartori, David J. Cohen, Adnan Kastrati, C. Michael Gibson, David J. Moliterno, Birgit Vogel, Javier Escaned, Gennaro Sardella, Timothy Collier, Dominick J. Angiolillo, Stuart Pocock, George D. Dangas, Roxana Mehran
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. 2:100654
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecddfaf89cef5c04f9fe41c61ccd336a
https://doi.org/10.1016/j.jscai.2023.100654
https://doi.org/10.1016/j.jscai.2023.100654
Autor:
David P. Faxon, David J. Moliterno, Jacqueline Saw, David R. Holmes, Jean Francois Tanguay, Shaun G. Goodman, Deepak L. Bhatt, Renato D. Lopes, C. Michael Gibson, Roxana Mehran, Christopher P. Cannon, Dominick J. Angiolillo, Christopher B. Granger, John W. Eikelboom, Matthew J. Price
Publikováno v:
Circulation. 143:583-596
A growing number of patients undergoing percutaneous coronary intervention (PCI) with stent implantation also have atrial fibrillation. This poses challenges for their optimal antithrombotic management because patients with atrial fibrillation underg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dbcd7e7932ab89a03846e979473dd9f
https://doi.org/10.1161/circulationaha.120.050438
https://doi.org/10.1161/circulationaha.120.050438
Autor:
David J, Moliterno
Publikováno v:
JACC: Cardiovascular Interventions. 15:2237-2238
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9c96a6057c72ddf76b9eebd5dad4a38
https://doi.org/10.1016/j.jcin.2022.10.006
https://doi.org/10.1016/j.jcin.2022.10.006